122 related articles for article (PubMed ID: 27417288)
1. Low-dose growth hormone therapy reduces inflammation in HIV-infected patients: a randomized placebo-controlled study.
Lindboe JB; Langkilde A; Eugen-Olsen J; Hansen BR; Haupt TH; Petersen J; Andersen O
Infect Dis (Lond); 2016; 48(11-12):829-37. PubMed ID: 27417288
[TBL] [Abstract][Full Text] [Related]
2. Long-term high-physiological-dose growth hormone reduces intra-abdominal fat in HIV-infected patients with a neutral effect on glucose metabolism.
Hansen BR; Haugaard SB; Jensen FK; Jensen JE; Andresen L; Iversen J; Andersen O
HIV Med; 2010 Apr; 11(4):266-75. PubMed ID: 20002779
[TBL] [Abstract][Full Text] [Related]
3. The effects of recombinant human growth hormone (rhGH) supplementation on adipokines and C-reactive protein in obese subjects.
Albert SG; Haas MJ; Mooradian AD
Growth Horm IGF Res; 2007 Feb; 17(1):19-25. PubMed ID: 17118687
[TBL] [Abstract][Full Text] [Related]
4. Effect of Recombinant Human Growth Hormone and Rosiglitazone for HIV-Associated Abdominal Fat Accumulation on Adiponectin and other Markers of Inflammation.
Leung V; Chiu YL; Kotler DP; Albu J; Zhu YS; Ham K; Engelson ES; Hammad H; Christos P; Donovan DS; Ginsberg HN; Glesby MJ
HIV Clin Trials; 2016 Mar; 17(2):55-62. PubMed ID: 27077672
[TBL] [Abstract][Full Text] [Related]
5. The effect of recombinant human growth hormone with or without rosiglitazone on hepatic fat content in HIV-1-infected individuals: a randomized clinical trial.
Kotler DP; He Q; Engelson ES; Albu JB; Glesby MJ
Antivir Ther; 2016; 21(2):107-16. PubMed ID: 25536669
[TBL] [Abstract][Full Text] [Related]
6. A randomized, placebo-controlled trial of combined insulin-like growth factor I and low dose growth hormone therapy for wasting associated with human immunodeficiency virus infection.
Lee PD; Pivarnik JM; Bukar JG; Muurahainen N; Berry PS; Skolnik PR; Nerad JL; Kudsk KA; Jackson L; Ellis KJ; Gesundheit N
J Clin Endocrinol Metab; 1996 Aug; 81(8):2968-75. PubMed ID: 8768860
[TBL] [Abstract][Full Text] [Related]
7. Effects of recombinant growth hormone on visceral fat accumulation: pilot study in human immunodeficiency virus-infected adolescents.
Viganò A; Mora S; Manzoni P; Schneider L; Beretta S; Molinaro M; di Natale B; Brambilla P
J Clin Endocrinol Metab; 2005 Jul; 90(7):4075-80. PubMed ID: 15840750
[TBL] [Abstract][Full Text] [Related]
8. Growth hormone, insulin-like growth factors and their binding proteins in adult hemodialysis patients treated with recombinant human growth hormone.
Jensen PB; Hansen TB; Frystyk J; Ladefoged SD; Pedersen FB; Christiansen JS
Clin Nephrol; 1999 Aug; 52(2):103-9. PubMed ID: 10480221
[TBL] [Abstract][Full Text] [Related]
9. Growth hormone treatment in hemodialysis patients--a randomized, double-blind, placebo-controlled study.
Ericsson F; Filho JC; Lindgren BF
Scand J Urol Nephrol; 2004; 38(4):340-7. PubMed ID: 15669595
[TBL] [Abstract][Full Text] [Related]
10. Comparison of body composition assessment methods in patients with human immunodeficiency virus-associated wasting receiving growth hormone.
Esposito JG; Thomas SG; Kingdon L; Ezzat S
J Clin Endocrinol Metab; 2006 Aug; 91(8):2952-9. PubMed ID: 16757527
[TBL] [Abstract][Full Text] [Related]
11. Low-dose recombinant human growth hormone as adjuvant therapy to lifestyle modifications in the management of obesity.
Albert SG; Mooradian AD
J Clin Endocrinol Metab; 2004 Feb; 89(2):695-701. PubMed ID: 14764783
[TBL] [Abstract][Full Text] [Related]
12. Recombinant human growth hormone and rosiglitazone for abdominal fat accumulation in HIV-infected patients with insulin resistance: a randomized, double-blind, placebo-controlled, factorial trial.
Glesby MJ; Albu J; Chiu YL; Ham K; Engelson E; He Q; Muthukrishnan V; Ginsberg HN; Donovan D; Ernst J; Lesser M; Kotler DP
PLoS One; 2013; 8(4):e61160. PubMed ID: 23593417
[TBL] [Abstract][Full Text] [Related]
13. GH treatment reduces trunkal adiposity in HIV-infected patients with lipodystrophy: a randomized placebo-controlled study.
Luzi L; Meneghini E; Oggionni S; Tambussi G; Piceni-Sereni L; Lazzarin A
Eur J Endocrinol; 2005 Dec; 153(6):781-9. PubMed ID: 16322383
[TBL] [Abstract][Full Text] [Related]
14. Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy.
Andersen O; Eugen-Olsen J; Kofoed K; Iversen J; Haugaard SB
J Med Virol; 2008 Feb; 80(2):209-16. PubMed ID: 18098145
[TBL] [Abstract][Full Text] [Related]
15. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
[TBL] [Abstract][Full Text] [Related]
16. Effects of tesamorelin, a growth hormone-releasing factor, in HIV-infected patients with abdominal fat accumulation: a randomized placebo-controlled trial with a safety extension.
Falutz J; Potvin D; Mamputu JC; Assaad H; Zoltowska M; Michaud SE; Berger D; Somero M; Moyle G; Brown S; Martorell C; Turner R; Grinspoon S
J Acquir Immune Defic Syndr; 2010 Mar; 53(3):311-22. PubMed ID: 20101189
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled pilot trial of valacyclovir for attenuating inflammation and immune activation in HIV/herpes simplex virus 2-coinfected adults on suppressive antiretroviral therapy.
Yi TJ; Walmsley S; Szadkowski L; Raboud J; Rajwans N; Shannon B; Kumar S; Kain KC; Kaul R; Tan DH
Clin Infect Dis; 2013 Nov; 57(9):1331-8. PubMed ID: 23946220
[TBL] [Abstract][Full Text] [Related]
18. A randomized controlled trial of low-dose recombinant human growth hormone in the treatment of malnourished elderly medical patients.
Chu LW; Lam KS; Tam SC; Hu WJ; Hui SL; Chiu A; Chiu KC; Ng P
J Clin Endocrinol Metab; 2001 May; 86(5):1913-20. PubMed ID: 11344184
[TBL] [Abstract][Full Text] [Related]
19. Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial.
Koutkia P; Canavan B; Breu J; Torriani M; Kissko J; Grinspoon S
JAMA; 2004 Jul; 292(2):210-8. PubMed ID: 15249570
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
